Roivant Sciences (ROIV) Revenue (2020 - 2026)
Roivant Sciences (ROIV) recorded Revenue of $1.44 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 33.5% from $2.17 million a year earlier and down 42.8% from the prior quarter.
Roivant Sciences (ROIV) Revenue (2020 - 2026) Analysis & Trends
On a TTM basis, Roivant Sciences' Revenue came in at $7.53 million as of Jun 30, 2026, down 67.6% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $8.26 million, down 71.6% from FY2025.
- Annual Revenue has a five-year compound annual growth rate of -19.1% (FY2021 to FY2026).
- Across earlier fiscal years, Revenue came in at $29.05 million in FY2025 (-11.2%), $32.71 million in FY2024 (+3.8%), $31.53 million in FY2023 (-43.0%) and $55.29 million in FY2022 (+132.3%).
- The fiscal Q1 2027 figure is the lowest quarterly Revenue since fiscal Q4 2023.
- On a year-over-year basis, Revenue has declined for seven consecutive quarters, with an average decline of 43.9% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 957.2% in fiscal Q2 2022, against a decline of 77.8% in fiscal Q3 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $2.52 million (Q4 2026), $2 million (Q3 2026) and $1.57 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Roivant Sciences | 26.38 Bn | 27.07 Bn | 1.16 Mn | 1.44 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 9.02 Mn |
| Dec 31, 2023 | 15.56 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 21.62 Mn |
| Mar 31, 2023 | -2.37 Mn |
| Dec 31, 2022 | 17.05 Mn |
| Sep 30, 2022 | 12.53 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 9.22 Mn |
| Dec 31, 2021 | 24.34 Mn |
| Sep 30, 2021 | 13.99 Mn |
Roivant Sciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ROIV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();